Evidence map›Paper›PMID 37408055›Full record

GuidelineRadiation oncology (London, England)2023

Target volume delineation for radiotherapy of meningiomas: an ANOCEF consensus guideline.

Nicolas Martz, Julia Salleron, Frédéric Dhermain, Guillaume Vogin, Jean-François Daisne, Raphaelle Mouttet-Audouard, Ronan Tanguy, Georges Noel, Matthieu Peyre, Isabelle Lecouillard and 13 more

Abstract readPractice GuidelineReview
In one paragraph

Guideline in Radiation oncology (London, England), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Nicolas MartzAcademic Department of Radiation Therapy & Brachytherapy, Institut de Cancérologie de Lorraine - Alexis-Vautrin Cancer Center, 6 avenue de Bourgogne - CS 30 519, Vandoeuvre Les Nancy, France. n.martz@nancy.unicancer.fr.
Julia SalleronCellule Data-biostatistiques, Institut de Cancérologie de Lorraine, Université de Lorraine, Vandœuvre-lés-Nancy, France.
Frédéric DhermainDepartment of Radiation Oncology, Gustave Roussy University Hospital, Villejuif, France.
Guillaume VoginAcademic Department of Radiation Therapy & Brachytherapy, Institut de Cancérologie de Lorraine - Alexis-Vautrin Cancer Center, 6 avenue de Bourgogne - CS 30 519, Vandoeuvre Les Nancy, France.
Jean-François DaisneDepartment of Radiation Oncology, University Hospitals Leuven, Catholic University of Leuven (KU Leuven), Leuven, Belgium.
Raphaelle Mouttet-AudouardAcademic Department of Radiotherapy, Oscar Lambret Comprehensive Cancer Centre, Lille, France.
Ronan TanguyDepartment of Radiotherapy, Léon Bérard Cancer Centre, Lyon, France.
Georges NoelRadiation Oncology Department, Paul Strauss Cancer Centre, Strasbourg, France.
Matthieu PeyreDepartment of Neurosurgery, Sorbonne Université, Groupe Hospitalier Pitié-Salpêtrière, Paris, France.
Isabelle LecouillardDepartment of Radiation Oncology, Eugène Marquis Cancer Centre, Rennes, France.
Julian JacobDepartment of Radiation Oncology, Hôpital Pitié-Salpêtrière Charles Foix, APHP, Paris, France.
Justine AttalRadiotherapy Department, Institut Claudius Regaud, Toulouse University Institute for Cancer (IUCT-Oncopole), Toulouse, France.
Marie CharissouxRadiation Oncology Department, Centre Val d'Aurelle, Montpellier, France.
Ovidiu VeresezanDepartment of Radiation Oncology, Cancer Centre Henri Becquerel, Rouen, France.
Chantal HanzenDepartment of Radiation Oncology, Centre Hospitalier et Universitaire, Bordeaux, France.
Aymeri HuchetDepartment of Radiation Oncology, Centre Hospitalier et Universitaire, Bordeaux, France.
Igor LatorzeffDepartment of Radiotherapy, Groupe ONCORAD Garonne and Clinique Pasteur, Toulouse, France.
Alexandre CoutteDepartment of Radiation Therapy, CHU d'Amiens, Amiens, France.
Jérôme DoyenDepartment of Radiation Therapy, Antoine Lacassagne Cancer Center, University of Nice- Sophia, Nice, France.
Dinu StefanDepartment of Radiation Oncology, François Baclesse Cancer Centre, Caen, France.
Loic FeuvretDepartment of Radiation Oncology, Hôpital Pitié-Salpêtrière Charles Foix, APHP, Paris, France.
Gabriel C T E GarciaDepartment of Diagnostic Radiology, Gustave Roussy, Villejuif, F-94800, France.
Philippe RoyerAcademic Department of Radiation Therapy & Brachytherapy, Institut de Cancérologie de Lorraine - Alexis-Vautrin Cancer Center, 6 avenue de Bourgogne - CS 30 519, Vandoeuvre Les Nancy, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeRadiotherapy is, with surgery, one of the main therapeutic treatment strategies for meningiomas. No prospective study has defined a consensus for the delineation of target volumes for meningioma radiotherapy. Therefore, target volume definition is mainly based on information from retrospective studies that include heterogeneous patient populations. The aim is to describe delineation guidelines for meningioma radiotherapy as an adjuvant or definitive treatment with intensity-modulated radiation therapy and stereotactic radiation therapy techniques. This guideline is based on a consensus endorsed by a multidisciplinary group of brain tumor experts, members of the Association of French-speaking Neuro-oncologists (ANOCEF). MATERIALS AND

methodsA 3-step procedure was used. First, the steering group carried out a comprehensive review to identify divergent issues on meningiomas target volume delineation. Second, an 84-item web-questionnaire has been developed to precisely define meningioma target volume delineation in the most common clinical situations. Third, experts members of the ANOCEF were requested to answer. The first two rounds were completed online. A third round was carried out by videoconference to allow experts to debate and discuss the remaining uncertain questions. All questions remained in a consensus.

resultsLimits of the target volume were defined using visible landmarks on computed tomography and magnetic resonance imaging, considering the pathways of tumor extension. The purpose was to develop clear and precise recommendations on meningiomas target volumes.

conclusionNew recommendations for meningiomas delineation based on simple anatomic boundaries are proposed by the ANOCEF. Improvement in uniformity in target volume definition is expected.

Indexed as

Meningeal NeoplasmsMeningiomaRadiotherapy, Intensity-ModulatedHumansMagnetic Resonance ImagingRadiotherapy Planning, Computer-AssistedRetrospective StudiesConsensus guidelinesDelineationMeningiomasRadiotherapyTarget volume

Identifiers

PMID37408055
PMCPMC10324255

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.